All lobbying filings

THORN RUN PARTNERS

Lobbying for THE BIOSIMILARS FORUM · Non-profit Organization

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $100,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
HR 5526
Biosimilar Red Tape Elimination Act
S 1954
Biosimilar Red Tape Elimination Act

Lobbying activity 2

Health Issues

Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.

Medicare/Medicaid

Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.